Three of Europe's top financiers outline what European biotechs need to do to raise private funds and survive in the continually challenging funding environment. By Melanie Senior The top 25 health ca
Unusually, the VC investors in UK-based Microscience have announced they will pump a further £10 million into the vaccine developer as it tries to enter the lukewarm public markets with a summer IPO o